オプティカル・コヒーレンス・トモグラフィー - ハンティントン病の初期生物マーカーの可能性
Clancy Cerejo1, Elias Mandler1, Federico Carbone1
1Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, Innsbruck, 6020, Austria.
Neurological research and practice
|August 28, 2025
まとめ
スペクトル領域の光学相関トモグラフィー (OCT) は,ハンチントン病における網膜の薄い層を検出する.
科学分野:
- 眼科と神経科学
- 神経変性疾患のバイオマーカーの発見
背景:
- ハンチントン病 (HD) は進行性神経変性疾患です.
- 神経変性症の早期発見とモニタリングは HDの管理に不可欠です.
- オプティカル・コーヘランス・トモグラフィー (OCT) は,網膜の層の非侵襲的なイメージングを可能にします.
研究 の 目的:
- ハンティントン病 (HD) の潜在的なバイオマーカーとして光学相関トモグラフィ (OCT) を評価する.
- HD患者と健康な対照群の網膜層の厚さを比較する.
- OCTの発見と疾患の重症度と認知/嗅覚機能の関連付け
主な方法:
- 39人のHD患者 (第1段階と第2段階) と29人のHC患者で,スペクトル領域のOCTデータ,認知機能,嗅覚機能を比較した横断的な研究.
- HD患者は,運動症状と機能能力に基づいてステージ化されました.
- 網膜神経繊維層 (RNFL) と ギャングリア細胞内部のプレキシフォーム層 (GCIPL) の厚さは,OCTを用いて測定された.
主要な成果:
- 初期段階を含むHD患者は,HCと比較して,マキュラ網膜神経繊維層 (mRNFL) とギャングリオン細胞内 Plexiform層 (GCIPL) の厚さが著しく減少した.
- ステージ2のHD患者はステージ1の患者より 運動機能,機能能力,認知能力が悪かった.
- OCTパラメータ (mRNFLとGCIPL) は,疾患負担 (PINHD,CAP) と嗅覚機能障害と相関しています.
結論:
- 網膜層の厚さの減少 (mRNFLとGCIPL) は,HD患者において,病気の初期段階でも顕著である.
- ハンチントン病の神経変異の検出とモニタリングのための 敏感なバイオマーカーとしての可能性を示しています
- これらの発見は,病気の初期段階の評価と病気の進行を追跡するためのOCTの有用性を支持しています.
関連する概念動画
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961
01:29Alzheimer Disease l: Introduction
38
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
38
01:23Alzheimer Disease ll: Pathophysiology
44
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
44
01:21Huntington Disease l: Introduction
166
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
166